Please login to the form below
pricing
This page shows the latest pricing news and features for those working in and with pharma, biotech and healthcare.
Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
Merck &Co joins big pharma pricing pledge – but sceptics unconvinced. ... These elements are all coming together to produce a very different tone on pharma pricing, but just how far it will extend into policy and legislation is yet to be seen.
Latest news
-
Novartis follows Pfizer and freezes US prices this year
s drug pricing policy – although Narasimhan said he thinks this matter has now been resolved. ... However, sales at Sandoz were flat overall as pricing pressure pegged back small-molecule generics in the US.
-
Novartis rejects claims it misled Senate over Cohen links
Novartis rejects claims it misled Senate over Cohen links. Report says Novartis discussed drug-pricing with the President’s former ‘fixer’. ... It also takes issue with claims that it made payments to Cohen try to influence US medicine pricing
-
Pfizer builds gap between pharma and consumer health units
Pricing backdown. The new guaranteed Pfizer continued to dominate the pharma news flow this week, coming just after the company reversed July 1 price rises for some of its products after
-
NHS England says yes to Roche's Hemlibra
While NICE is England’s best known market access gatekeeper, NHS England is in direct control of specialised commissioning, and negotiates directly on pricing and reimbursement on a select number of
-
Vertex calls NHS England ‘outrageous’ as talks stall on Orkambi access
Public row about confidential pricing talks drags on. Negotiations between Vertex and NHS England on a pricing and access deal for the cystic fibrosis (CF) drug Orkambi have stalled once again, ... However the truth of who, if anyone, is being
More from news
Approximately 93 fully matching, plus 827 partially matching documents found.
Latest Intelligence
-
Can new data aggregators shift the balance of power away from pharma?
This could have far-reaching consequences for some players in the pharmaceutical industry who may find their product pricing to be untenable when the cost/clinical benefit calculus becomes totally transparent.
-
Mylan sees the UK paving the way for an insulin game changer
A traditional approach to the costs of production and pricing is also hampering progress, according to Glinka. ... We are looking at a hybrid solution that offers favourable pricing and increased access for the patients.
-
30 Women Leaders in UK Healthcare
As Chair of the Industry Negotiating Board for PPRS, she will be central to the sector securing the best possible deal from the all-important pricing agreement.
-
Patient outcomes in practice: delivering value that transforms lives
Providers, payers and manufacturers all have a role in achieving value, with increasing ethical pressure on drug pricing and resultant innovative, outcomes-based pricing models.
-
The NHS and ABPI at 70: inching closer to the triple win
Stevens said he believed there was still a need for an overarching UK pricing agreement, such as the PPRS, but NHS England’s role as the gatekeeper for new drugs - especially
More from intelligence
Approximately 16 fully matching, plus 138 partially matching documents found.
Latest appointments
-
Weekly comms appointments
Pyati’s new domain will see him grow and expand the group’s scientific and medical communications practice and integrating it with the firm’s analytics, digital and value, pricing and
-
Claes Buxfeldt joins NDA
He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.
-
Mereo BioPharma appoints head of patient access and commercial planning
In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and led pricing, reimbursement and access teams for the group’s rare disease product portfolio.
-
W2O bolsters its commercialisation offering
W2O bolsters its commercialisation offering. Rita Glaze joins the firm as leader of value, pricing and market access practice. ... Glaze has 25 years’experience in the biopharmaceutical and life science sector with expertise in marketing, managed
-
Hanover Brussels appoints Aurélie Marchand as account director
Coming from a country where market access and negotiations around pricing and reimbursement can be challenging, I’m eager to bring this experience to the EU level.”.
More from appointments
Approximately 2 fully matching, plus 27 partially matching documents found.
Latest from PMHub
-
Valid Insight
With a team that includes some of the world’ s leading market access and pricing experts, our clients trust us to help them navigate through the most challenging environments. ... We focus on pricing, market access and value communication strategy
-
Remap Consulting
Remap Consulting. Remap Consulting is a specialist pharmaceutical pricing and market access consultancy. ... Our mission is to help solve your pricing and market access challenges to ensure improved patient access to your products.
-
Organisational Memory
Then, a whole swathe of people are needed to get the product onto the market in the first place: pricing and reimbursement experts, government affairs, public relations people, and patient relations
-
When data are not enough...
support premium pricing. increase the impact of promotional efforts. achieve product loyalty.
-
Understanding Patient Willingness to Pay
What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets? ... Any successful pricing strategy therefore needs to start with an understanding of target patients’ willingness to pay
More from PMHub
Approximately 6 fully matching, plus 52 partially matching documents found.
Featured jobs
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Business Unit Head, Medical Communications, London
-
Excellent package
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
Subscribe to our email news alerts
- Moving annual total (MAT)
- Brexit rebels win vote on European Medicines Agency alignment
- MaxCyte gets green light for solid tumour cell therapy
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- NHS England to Vertex: come clean on Orkambi offer
- AstraZeneca joins Merck in Brexit stockpiling effort
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
M3 (EU)
M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
